Trauma Patients with Pulmonary Contusion. Pulmonary candidiasis
Conditions
Interventions
Intervention 1: Intervention group: Cryoprecipitate recipient group. Intervention 2: Control group: Group with usual Treatment and Placebo.
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with Severe Blunt Lung Trauma Who Developed Lung Contusion with a Volume Involvement of More Than Ten Percent (Lung Tissue Damage Caused by Serious Trauma) Ages 18 to 65 Years Absence of Pulmonary Diseases and Certain Non-Pulmonary Diseases Such as Cancers Consent to Participate in the study
Exclusion criteria
Exclusion criteria: Penetrating Chest Trauma Severe Trauma, Such as Cerebral Hemorrhage, which Increases the Risk of Mortality Intolerance to Cryoprecipitate Having Serious Side Effects from Treatment (Such as Severe Infection or Allergic Reactions) Specific Medical Conditions that Contraindicate the Use of Cryoprecipitate (e.g., History of Incurable Coagulation Disorders) Having Lung Diseases such as COPD and Certain Non-Pulmonary Diseases Such as Cancers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of Improvement in the Patient's Respiratory Function. Timepoint: 24 hours. Method of measurement: Monitoring Patients with Clinical Symptoms, Arterial Oxygen Saturation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Torabi
Kerman University of Medical Sciences
Outcome results
None listed